Tamoxifen FDA Link Generic

One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM.

Also Known As:

ICI-46,474; ICI-46474; ICI-47699; Nolvadex; Novaldex; Soltamox; Tamoxifen Citrate; Tomaxithen; Zitazonium; Citrate, Tamoxifen; ICI 46,474; ICI 46474; ICI 47699; ICI46,474; ICI46474; ICI47699; Ethanamine, 2- (4- (1,2- diphenyl- 1- butenyl)phenoxy)- N,N- dimethyl- , (Z)-

Pharmalogical Action Categories:

Antineoplastic Agents, Hormonal
Bone Density Conservation Agents
Estrogen Antagonists
Selective Estrogen Receptor Modulators

Organic Chemicals: 140
- Hydrocarbons: 1726
  - Cyclic Hydrocarbons: 96
    - Aromatic Hydrocarbons: 295
      - Benzene Derivatives: 17
        Benzylidene Compounds: 10
        Stilbenes: 678
        Tamoxifen: 14434

Li-Mimg Zhou Selected Research

Li-Mimg Zhou Research Topics

Disease

Drug/Important Bio-Agent (IBA)